Peripheral Arterial Disease Trial, Recruiting NCT06409949 Sponsor: University of Nebraska Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06409949
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a long-term history of claudication (leg pain or cramping during walking caused by poor blood flow)
  • People whose claudication limits their ability to exercise, as confirmed by a vascular surgeon through observation during a walking test
  • People who have been diagnosed with blocked or narrowed arteries in their legs, confirmed through blood pressure measurements at the ankle compared to the arm, and/or medical imaging
  • People whose blood pressure, cholesterol, and diabetes (if applicable) have been stable and well-managed for at least 6 weeks

Who may not be able to join:

  • People who experience leg pain while resting, or who have wounds or tissue damage caused by poor blood flow in the legs (known as advanced stages of peripheral artery disease)
  • People who have recently had a sudden, severe loss of blood flow to a leg
  • People whose ability to walk is mainly limited by conditions other than leg artery problems, such as joint or muscle problems, nerve conditions, heart disease, or lung disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Iraklis Pipinos, MD, University of Nebraska

Phone: 402-995-4171

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Nebraska
Registry
ClinicalTrials.gov
Start date
1 June 2023
Est. completion
1 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Walking Impairment: maximum treadmill distance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov